Video Experimental Relacionado
Updated: Sep 10, 2025
11:47
Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
Published on: April 3, 2019
9.3K
El receptor P2X7 en la leucemia: mecanismos patológicos y potencial terapéutico
Yanwen Xue1,2, Xiaoxiang Peng1,2, Meng Yan1,2
1School of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, China.
Purinergic signalling
|August 22, 2025
Resumen
El receptor P2X7 está implicado en el desarrollo y la progresión de la leucemia. Dirigirse a este receptor, particularmente con inhibidores, se muestra prometedor como una nueva estrategia terapéutica para pacientes con leucemia.
Área de la Ciencia:
- Inmunología
- En el campo de la oncología
- Farmacología
Sus antecedentes:
- El receptor P2X7, un canal iónico trímero, está involucrado en enfermedades inflamatorias y cánceres.
- La leucemia es un trastorno de células madre hematopoyéticas que a menudo se trata con quimioterapia, que tiene efectos secundarios.
- Las terapias dirigidas están surgiendo como una nueva modalidad de tratamiento para la leucemia.
Objetivo del estudio:
- Para investigar el papel del receptor P2X7 en la leucemia.
- Para explorar el potencial del receptor P2X7 como objetivo terapéutico en la leucemia.
Principales métodos:
- Revisión de la investigación existente sobre el receptor P2X7 en el cáncer y la leucemia.
- Análisis de la participación del receptor P2X7 en la migración e invasión de las células leucémicas.
- Examen del impacto del polimorfismo del gen del receptor P2X7 en la leucemia.
Principales resultados:
- El receptor P2X7 está significativamente relacionado con la aparición y progresión de la leucemia.
- El receptor P2X7 influye en la migración e invasión de las células leucémicas.
- Los polimorfismos en el gen del receptor P2X7 afectan el desarrollo y el curso clínico de la leucemia.
Conclusiones:
- El receptor P2X7 es un objetivo terapéutico potencial para la leucemia.
- Los inhibidores del receptor P2X7 pueden mejorar los tratamientos existentes para la leucemia.
Palabras clave:
El ATPLa inmunorregulaciónLa leucemiaPolimorfismo del gen P2X7El receptor P2X7Antagonista de los receptores P2X7Más Videos Relacionados
Videos de Conceptos Relacionados
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
01:27Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K